US drug approvals
44 approvals with a product on the US market
- Tofacitinib Citrate ANDA219395 · approved 3 Jun 2026
- Buprenorphine Hydrochloride ANDA218473 · approved 10 Dec 2025
- Prucalopride Succinate ANDA219193 · approved 24 Jun 2025
- Lisdexamfetamine Dimesylate ANDA218850 · approved 17 Dec 2024
- Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate ANDA211546 · approved 31 Aug 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.